Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival.
No Comments »
Filed under: General Health News
Moderate drinkers often have lower risks of Alzheimer’s disease and other cognitive loss, according to researchers who reviewed 44 studies.
No Comments »
Filed under: General Health News
The Centers for Disease Control and Prevention and the American College of Sports Medicine recommends at least 30 minutes of moderate-intensity physical activity on most days of the week in order to maintain and improve optimal health.
No Comments »
Filed under: General Health News
Ipsen has announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter for its Biologics License Application (BLA) for its Botulinum toxin Type A, Dysport.
No Comments »
Filed under: General Health News
By mixing and matching a contemporary flu virus with the “Spanish flu” - a virus that killed between 20 and 50 million people 90 years ago in history’s most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.
No Comments »
Filed under: General Health News
New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease.
No Comments »
Filed under: General Health News
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
No Comments »
Filed under: General Health News
Savient Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s Biologics License Application (BLA) for pegloticase, a novel biological drug for treatment-failure gout (TFG) patients.
No Comments »
Filed under: Pharmacy News
Ipsen has announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter for its Biologics License Application (BLA) for its Botulinum toxin Type A, Dysport.
No Comments »
Filed under: Pharmacy News
Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.
No Comments »
Filed under: Pharmacy News
